Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119166) titled 'Observation on the clinical efficacy and safety of autologous hematopoietic stem cell transplantation combined with CAR-T cells in the treatment of relapsed/refractory multiple myeloma: A single-arm, single-center study' on Feb. 24.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: The First Affiliated Hospital of Wenzhou Medical University
Condition:
Multiple myeloma
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-02-24
Target Sample Size: Intervention group:20;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/show...